News >

Vitamin D Could Serve as Biomarker for Aggressive Prostate Cancer

Tony Berberabe, MPH @OncBiz_Wiz
Published: Monday, Mar 07, 2016

Adam Murphy, MD

Adam Murphy, MD

The level of vitamin D in a patient’s blood could serve as a biomarker for an aggressive form of prostate cancer, especially in men who are considering active surveillance for the disease. A new study from the Northwestern University Feinberg School of Medicine suggests a link between low levels of the vitamin and aggressive prostate cancer.

Nyame YA, Murphy AB, Bowen DK, et al. Associations between serum vitamin D and adverse pathology in men undergoing radical prostatectomy. [published online before print February 22, 2016]. J Clin Oncol. doi: 10.1200/JCO.2015.65.1463.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication